These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23751236)

  • 1. A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study.
    Brownley KA; Von Holle A; Hamer RM; La Via M; Bulik CM
    J Psychosom Res; 2013 Jul; 75(1):36-42. PubMed ID: 23751236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Double-Blind, Randomized Pilot Trial of Chromium Picolinate for Overweight Individuals with Binge-Eating Disorder: Effects on Glucose Regulation.
    Sala M; Breithaupt L; Bulik CM; Hamer RM; La Via MC; Brownley KA
    J Diet Suppl; 2017 Mar; 14(2):191-199. PubMed ID: 27835050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving.
    Docherty JP; Sack DA; Roffman M; Finch M; Komorowski JR
    J Psychiatr Pract; 2005 Sep; 11(5):302-14. PubMed ID: 16184071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial.
    White MA; Grilo CM
    J Clin Psychiatry; 2013 Apr; 74(4):400-6. PubMed ID: 23656848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naltrexone + Bupropion Combination for the Treatment of Binge-eating Disorder with Obesity: A Randomized, Controlled Pilot Study.
    Grilo CM; Lydecker JA; Morgan PT; Gueorguieva R
    Clin Ther; 2021 Jan; 43(1):112-122.e1. PubMed ID: 33218742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of chromium picolinate for weight loss.
    Yazaki Y; Faridi Z; Ma Y; Ali A; Northrup V; Njike VY; Liberti L; Katz DL
    J Altern Complement Med; 2010 Mar; 16(3):291-9. PubMed ID: 20192914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial.
    Singer GM; Geohas J
    Diabetes Technol Ther; 2006 Dec; 8(6):636-43. PubMed ID: 17109595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as.
    Grilo CM; White MA
    Behav Res Ther; 2013 Mar; 51(3):167-75. PubMed ID: 23376451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Dasotraline in Adults With Binge-Eating Disorder: A Randomized, Placebo-Controlled, Flexible-Dose Clinical Trial.
    McElroy SL; Hudson JI; Grilo CM; Guerdjikova AI; Deng L; Koblan KS; Goldman R; Navia B; Hopkins S; Loebel A
    J Clin Psychiatry; 2020 Sep; 81(5):. PubMed ID: 32926604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors and moderators of response to cognitive behavioral therapy and medication for the treatment of binge eating disorder.
    Grilo CM; Masheb RM; Crosby RD
    J Consult Clin Psychol; 2012 Oct; 80(5):897-906. PubMed ID: 22289130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double-blind, placebo-controlled trials in adults with binge-eating disorder.
    McElroy SL; Hudson JI; Gasior M; Herman BK; Radewonuk J; Wilfley D; Busner J
    Int J Eat Disord; 2017 Aug; 50(8):884-892. PubMed ID: 28481434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind study.
    Wilfley DE; Crow SJ; Hudson JI; Mitchell JE; Berkowitz RI; Blakesley V; Walsh BT;
    Am J Psychiatry; 2008 Jan; 165(1):51-8. PubMed ID: 18056225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial.
    McElroy SL; Hudson JI; Mitchell JE; Wilfley D; Ferreira-Cornwell MC; Gao J; Wang J; Whitaker T; Jonas J; Gasior M
    JAMA Psychiatry; 2015 Mar; 72(3):235-46. PubMed ID: 25587645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial.
    Grilo CM; Lydecker JA; Fineberg SK; Moreno JO; Ivezaj V; Gueorguieva R
    Am J Psychiatry; 2022 Dec; 179(12):927-937. PubMed ID: 36285406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder.
    Grilo CM; Crosby RD; Wilson GT; Masheb RM
    J Consult Clin Psychol; 2012 Dec; 80(6):1108-13. PubMed ID: 22985205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of binge eating disorder.
    Wilson GT
    Psychiatr Clin North Am; 2011 Dec; 34(4):773-83. PubMed ID: 22098803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial.
    Guerdjikova AI; McElroy SL; Winstanley EL; Nelson EB; Mori N; McCoy J; Keck PE; Hudson JI
    Int J Eat Disord; 2012 Mar; 45(2):281-9. PubMed ID: 21744377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A placebo-controlled pilot study of the novel opioid receptor antagonist ALKS-33 in binge eating disorder.
    McElroy SL; Guerdjikova AI; Blom TJ; Crow SJ; Memisoglu A; Silverman BL; Ehrich EW
    Int J Eat Disord; 2013 Apr; 46(3):239-45. PubMed ID: 23381803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study protocol and rationale for a randomized, placebo-controlled trial of solriamfetol to treat binge eating disorder.
    Guerdjikova AI; Romo-Nava F; Blom TJ; Mori N; McElroy SL
    Contemp Clin Trials; 2021 Nov; 110():106587. PubMed ID: 34610482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone plus bupropion combination medication maintenance treatment for binge-eating disorder following successful acute treatments: randomized double-blind placebo-controlled trial.
    Grilo CM; Lydecker JA; Gueorguieva R
    Psychol Med; 2023 Dec; 53(16):7775-7784. PubMed ID: 37366017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.